MALL, also known as MAL-like protein, is a protein believed to be involved in protein trafficking processes, specifically in the transport of proteins and lipids between various cellular compartments. This protein is part of the MAL family, which includes proteins that play roles in the biogenesis and function of specialized lipid rafts. Lipid rafts are microdomains in cellular membranes that serve as platforms for signal transduction and protein sorting. They are enriched in cholesterol, glycosphingolipids, and specific proteins, helping to compartmentalize cellular processes by organizing the assembly of signaling molecules, influencing membrane fluidity and trafficking of membrane proteins.
Inhibitors targeting MALL are chemicals or molecules that modulate the function, expression, or interactions of the MALL protein. Given MALL's role in protein trafficking and lipid raft function, inhibitors could potentially alter these processes by preventing MALL from executing its normal activities. The design of such inhibitors could focus on interrupting the interactions between MALL and its binding partners or substrates, which would disrupt the trafficking processes or lipid raft functions it mediates. Alternatively, MALL inhibitors might interfere with the expression, stability, or post-translational modifications of the MALL protein, leading to altered cellular trafficking or signaling. Understanding the nature and specificity of MALL inhibitors provides insights into the fundamental mechanisms of protein transport and lipid raft dynamics. The investigation into MALL and its inhibitors offers a unique perspective on the complex networks of cellular transport and highlights the intricacies of protein interactions in these processes.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
hydroxychloroquine | 118-42-3 | sc-507426 | 5 g | $57.00 | 1 | |
Used as an anti-malarial, it can modulate TLR signaling and might affect MAL (TIRAP) expression or function. | ||||||
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $67.00 $284.00 | 6 | |
A TLR7 agonist, it can induce TLR signaling and potentially influence MAL (TIRAP) levels. | ||||||
Resatorvid | 243984-11-4 | sc-476758 | 5 mg | $367.00 | ||
A TLR4 inhibitor that might indirectly modulate MAL (TIRAP) expression or function. | ||||||
Pyrrolidinedithiocarbamic acid ammonium salt | 5108-96-3 | sc-203224 sc-203224A | 5 g 25 g | $33.00 $64.00 | 11 | |
Inhibits NF-κB activation, a downstream event in TLR signaling, which might affect MAL (TIRAP) levels. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $81.00 $306.00 | 32 | |
Inhibits IκB kinase β (IKKβ), affecting NF-κB activation and possibly influencing MAL (TIRAP). | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Inhibits IκBα phosphorylation, affecting NF-κB activation and potentially MAL (TIRAP) expression. | ||||||
BAY 11-7085 | 196309-76-9 | sc-202490 sc-202490A | 10 mg 50 mg | $124.00 $526.00 | 55 | |
Another inhibitor of NF-κB activation which could impact MAL (TIRAP) levels. | ||||||